[New therapy with blood components in vascular diseases of fundus oculi].

The concentrations of the hemostatic system components (plasminogen, fibronectin, alpha 2-macroglobulin, alpha 1 proteinase inhibitor, and antithrombin III) were measured in activated and intact plasma. Activated autoplasma was used in the treatment of patients with central chorioretinal dystrophy. After therapy vision acuity increased in 74.3% (52 eyes) and did not change in 25.7% (18 eyes) of cases.